CO - Global Cord Blood Corporation

NYSE - NYSE Delayed Price. Currency in USD
6.44
+0.18 (+2.88%)
At close: 4:02PM EDT
Stock chart is not supported by your current browser
Trade prices are not sourced from all markets
Previous Close6.26
Open6.29
Bid6.44 x 1000
Ask6.45 x 1100
Day's Range6.25 - 6.49
52 Week Range5.67 - 10.12
Volume18,640
Avg. Volume40,258
Market Cap782.788M
Beta (3Y Monthly)0.24
PE Ratio (TTM)21.98
EPS (TTM)0.29
Earnings DateFeb 25, 2019 - Mar 1, 2019
Forward Dividend & Yield0.08 (1.19%)
Ex-Dividend Date2018-07-31
1y Target Est15.00
  • Markit12 days ago

    See what the IHS Markit Score report has to say about Global Cord Blood Corp.

    Global Cord Blood Corp NYSE:COView full report here! Summary * ETFs holding this stock are seeing positive inflows * Bearish sentiment is low Bearish sentimentShort interest | PositiveShort interest is extremely low for CO with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting CO. Money flowETF/Index ownership | PositiveETF activity is positive. Over the last month, ETFs holding CO are favorable, with net inflows of $202 million. Additionally, the rate of inflows is increasing. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Here’s What Hedge Funds Think About Global Cord Blood Corporation (CO)
    Insider Monkey17 days ago

    Here’s What Hedge Funds Think About Global Cord Blood Corporation (CO)

    Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of December. At Insider Monkey, we follow nearly 750 active hedge funds and notable investors and by analyzing their 13F filings, we can determine the stocks that they are […]

  • PR Newswire2 months ago

    Global Cord Blood Corporation Raised Subscription Fee

    HONG KONG, April 1, 2019 /PRNewswire/ -- Global Cord Blood Corporation (CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company is increasing its processing fee by RMB3,000 to RMB9,800, effective on April 1, 2019. The Company's annual storage fee is unaffected by this increase. The Company is committed to delivering high quality and top of the line services to all clients, and this is evidenced by the Company's continuous investment in cord blood banking hardware as well as software.

  • Thomson Reuters StreetEvents3 months ago

    Edited Transcript of CO earnings conference call or presentation 26-Feb-19 1:00pm GMT

    Q3 2019 Global Cord Blood Corp Earnings Call

  • PR Newswire3 months ago

    Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2019

    3Q 19 Added 23,663 New Subscribers Revenues Up 3.7% YoY to RMB254.2 Million ( $37.0 Million )  Operating   Income Increased to RMB92.6 Million ( $13.5 Million ) Conference Call to be Held on February 26, ...

  • PR Newswire3 months ago

    Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2019 Financial Results

    Earnings Call Scheduled for 8:00 a.m. ET on February 26, 2019 HONG KONG , Feb. 19, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"), China's leading provider of cord ...

  • Thomson Reuters StreetEvents5 months ago

    Edited Transcript of CO earnings conference call or presentation 28-Nov-18 1:00pm GMT

    Q2 2019 Global Cord Blood Corp Earnings Call

  • PR Newswire6 months ago

    Global Cord Blood Corporation Announces Results of 2018 Annual General Meeting

    HONG KONG , Dec. 6, 2018 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic ...

  • Want To Invest In Global Cord Blood Corporation (NYSE:CO)? Here’s How It Performed Lately
    Simply Wall St.6 months ago

    Want To Invest In Global Cord Blood Corporation (NYSE:CO)? Here’s How It Performed Lately

    After reading Global Cord Blood Corporation’s (NYSE:CO) latest earnings update (30 June 2018), I found it beneficial to look back at how the company has performed in the past and Read More...

  • PR Newswire6 months ago

    Global Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2019

      2Q19 Added 22,908 New Subscribers Revenues Up 5.3% YoY to RMB247.1 Million ( $36.0 Million )                                    Operating   Income Up 37.3% YoY to RMB104.8 Million ( $15.3 Million )   ...

  • Can Global Cord Blood Corporation (NYSE:CO) Improve Its Returns?
    Simply Wall St.6 months ago

    Can Global Cord Blood Corporation (NYSE:CO) Improve Its Returns?

    One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return Read More...

  • PR Newswire6 months ago

    Global Cord Blood Corporation to Report Second Quarter and First Half Fiscal 2019 Financial Results

    Earnings Call Scheduled for 8:00 a.m. ET on November 28 , 2018 HONG KONG , Nov. 20, 2018 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"), China's leading provider of ...